Dpp-4 Inhibition Improves Cardiac Function Following Experimental Myocardial Infarction: Potential Non-glp-1 Mediated Effects

被引:0
|
作者
Connelly, Kim A.
Zhang, Yanling
Desjardins, Jean-Francois
Golam, Kabir
Advani, Andrew
Gilbert, Richard E.
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Rsch Cntr, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
Type; 1; Diabetes; Myocardial infarction; Chemokines;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
13148
引用
收藏
页数:1
相关论文
共 50 条
  • [31] CHRONIC DPP-4 INHIBITION BY SITAGLIPTIN IMPROVES GLOBAL MYOCARDIAL FUNCTION DURING DOBUTAMINE STRESS IN TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE
    McCormick, Liam M.
    Kydd, Anna
    Read, Philip
    Hoole, Stephen
    Dutka, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1531 - E1531
  • [32] DPP-4 inhibition increases GIP and decreases GLP-1 incretin effects during intravenous glucose tolerance test in Wistar rats
    Freyse, Ernst-Joachim
    Berg, Sabine
    Kohnert, Klaus-Dieter
    Heinke, Peter
    Salzsieder, Eckhard
    BIOLOGICAL CHEMISTRY, 2011, 392 (03) : 209 - 215
  • [33] ACE inhibition and all blockade following experimental myocardial infarction: Effects on ventricular hypertrophy, remodeling and function
    Prahash, AJC
    Gupta, S
    Anand, IS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 217A - 217A
  • [34] DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion
    Hui-Chun Ku
    Wen-Pin Chen
    Ming-Jai Su
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 384
  • [35] DPP4 deficiency preserves cardiac function via GLP-1 signaling in rats subjected to myocardial ischemia/reperfusion
    Ku, Hui-Chun
    Chen, Wen-Pin
    Su, Ming-Jai
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 384 (02) : 197 - 207
  • [36] Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
    Sinha, Binayak
    Ghosal, Samit
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 150 : 8 - 16
  • [37] IN VIVO STUDY OF ADENVIRUS MEDIATED TRANSGENIC HIF-1α AND ITS PROTECTIVE EFFECTS ON CARDIAC FUNCTION IN EXPERIMENTAL MYOCARDIAL INFARCTION
    Li Dongye
    Yan Yan
    Liu Yina
    Liu Chuang
    Zhu Hong
    Pan Defeng
    Zhang Zhuoqi
    Xia Yong
    HEART, 2010, 96 : A46 - A46
  • [38] Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
    Zaruba, Marc-Michael
    Theiss, Hans Diogenes
    Vallaster, Markus
    Mehl, Ursula
    Brunner, Stefan
    David, Robert
    Fischer, Rebekka
    Krieg, Lisa
    Hirsch, Eva
    Huber, Bruno
    Nathan, Petra
    Israel, Lars
    Imhof, Axel
    Herbach, Nadja
    Assmann, Gerald
    Wanke, Ruediger
    Mueller-Hoecker, Josef
    Steinbeck, Gerhard
    Franz, Wolfgang-Michael
    CELL STEM CELL, 2009, 4 (04) : 313 - 323
  • [39] Effect of a Novel Xanthine-Based DPP-4 Inhibitor (BI 14361) on Infarction Size and Cardiac Function in Rats after Myocardial Ischemia-Reperfusion
    Sharkovska, Yuliya
    Pfab, Thiemo
    Alter, Markus
    Von Websky, Karoline
    Mark, Michael
    Klein, Thomas
    Hocher, Berthold
    DIABETES, 2011, 60 : A267 - A267
  • [40] Differential importance of GIP vs. GLP-1 receptor signalling vs. DPP-4 inhibition for beta cell survival and function in mice
    Maida, A.
    Seino, Y.
    Drucker, D. J.
    DIABETOLOGIA, 2008, 51 : S363 - S364